Under Newborn Care section from Canadian Paediatric Society published on Aug 2018 Hemorrhagic disease of the newborn (HDNB) usually presents as unexpected bleeding, typically caused by vitamin K deficiency. Vitamin K deficiency is caused due to insufficient prenatal storage of vitamin K, along with a minimal amount of vitamin K in breast milk. To combat this issue, intramuscular (IM) Vitamin K is administered at the birth of a newborn. What Is This Guideline About?
The present guideline is developed by the Canadian Paediatric Society (CPS) to provide recommendations on the use of oral vitamin K for the treatment of vitamin K deficiency bleeding (VKDB). What Was The Need For The Guideline? Routine administration of IM vitamin K has the potential to cause psychological harm to the infants. To minimize the deleterious effects from early pain exposure and procedural pain in the neonate,…
